Investigating Resistance to Carbapenems in Enterobacterales: A Descriptive Epidemiological Study of 2021 Screening in an Italian Teaching Hospital.
New Delhi metallo-beta-lactamase (NDM)
antimicrobial resistance (AMR)
carbapenem-resistant enterobacterales (CRE)
carbapenemase-producing enterobacterales (CPE)
enterobacterales
hospital screening
infection control
multidrug-resistant organisms (MDROs)
rectal swabs
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
06 Sep 2023
06 Sep 2023
Historique:
received:
31
07
2023
revised:
29
08
2023
accepted:
05
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Antimicrobial resistance (AMR) presents a growing threat to global healthcare. This descriptive epidemiological study investigates the prevalence and characteristics of Enterobacterales with AMR factors in a tertiary teaching hospital in Italy over the course of the year 2021. In 2021, the prevalence of colonisation by Enterobacterales with AMR factors in patients was 1.08%. During the observation period, a total of 8834 rectal swabs were performed, with 1453 testing positive. A total of 5639 rectal swabs were performed according to a hospital procedure for the active screening of MDRO colonisation at the time of admission. Of these, 679 were positive for microorganisms under surveillance, and 74 patients were colonised with Enterobacterales, predominantly
Identifiants
pubmed: 37764948
pii: pathogens12091140
doi: 10.3390/pathogens12091140
pmc: PMC10535761
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
New Microbiol. 2022 Dec;45(4):338-343
pubmed: 36538299
J R Coll Physicians Edinb. 2021 Mar;51(1):24-30
pubmed: 33877130
Clin Microbiol Infect. 2012 Jan;18(1):54-60
pubmed: 21722257
J Hosp Infect. 2013 Apr;83(4):330-2
pubmed: 23415499
Clin Infect Dis. 2023 Jul 5;77(Suppl 1):S46-S52
pubmed: 37406046
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
J Antimicrob Chemother. 2016 Dec;71(12):3556-3561
pubmed: 27516471
J Hosp Infect. 2018 Sep;100(1):29-34
pubmed: 29879446
Transpl Infect Dis. 2022 Dec;24(6):e13920
pubmed: 35942941
Ann Intensive Care. 2011 Nov 23;1:47
pubmed: 22112929
Emerg Infect Dis. 2020 Jun;26(6):1156-1163
pubmed: 32267827
Infect Control Hosp Epidemiol. 2009 Oct;30(10):972-6
pubmed: 19712030
Clin Microbiol Infect. 2017 Jan;23(1):48.e9-48.e16
pubmed: 27642178
J Hosp Infect. 2021 Jul;113:164-171
pubmed: 33940090
Virulence. 2017 May 19;8(4):417-426
pubmed: 27813699
Euro Surveill. 2013 Jul 11;18(28):
pubmed: 23870096
J Infect. 2022 Feb;84(2):119-130
pubmed: 34793762
Infect Control Hosp Epidemiol. 1996 Mar;17(3):193-200
pubmed: 8708364
J Infect. 2019 Aug;79(2):115-122
pubmed: 31125639
Antimicrob Resist Infect Control. 2019 Aug 13;8:136
pubmed: 31423299
Front Microbiol. 2017 Feb 14;8:228
pubmed: 28261184
Clin Microbiol Infect. 2014 Jan;20 Suppl 1:1-55
pubmed: 24329732
Pathog Dis. 2019 Jun 1;77(4):
pubmed: 31281931
Infect Control Hosp Epidemiol. 2008 Dec;29(12):1099-106
pubmed: 18973455
Clin Infect Dis. 2012 Oct;55(7):943-50
pubmed: 22752516
Euro Surveill. 2020 Feb;25(6):
pubmed: 32070467
PLoS One. 2023 Mar 24;18(3):e0282019
pubmed: 36961857
Int J Environ Res Public Health. 2020 Oct 09;17(20):
pubmed: 33050318
Clin Microbiol Infect. 2016 Feb;22(2):162.e1-162.e9
pubmed: 26482264
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
J Hosp Infect. 2022 Nov;129:102-109
pubmed: 35690266
Clin Microbiol Infect. 2015 Mar;21(3):242-7
pubmed: 25658534
Am J Infect Control. 2016 May 1;44(5):539-43
pubmed: 26899297